The aim of this research was to extract and analyse lovastatin from edible wild mushrooms. Lovastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMG-CoA reductase) enzyme and a competitive inhibitor of the biosynthesis of cholesterol. Seven wild edible mushrooms species were analysed for the production of lovastatin. Bioassays, TLC and UV spectral analysis confirmed that six of the edible wild mushrooms were lovastatin producers, which showed zones of inhibition against Candida albicans, similar Rf values as that of standard and λ max at 238 nm. The production of lovastatin was also confirmed by high performance liquid chromatography (HPLC). Schizophyllum commune produced the highest concentration of lovastatin and its occurrence in the mushroom is reported for the first time. This mushroom can also serve as a potential species for genetic engineering and strain improvement studies to enhance the yield of lovastatin. Hence this property of mushrooms could be exploited in food and pharmaceutical industries.
Introduction
The World Health Organization estimated that 17.3 million lives were lost in 2008 and an expected 23.6 million people will die of cardiovascular diseases by the year 2030 (WHO, 2011) . About 80% of mortality rates were reported from the lower and middle income countries. The treatment of hypercholesterolemia is targeted by decreasing the low density lipoprotein by medications. A wide variety of biological active compounds are produced by fungi (De Silva et al. 2012a , 2012b , 2013 including statins (anti-cholesterol compounds) . Lovastatin is an interesting fungal metabolite. It functions as a competitive inhibitor of the enzyme, 3-hydroxy-3methyl-glutaryl enzyme in cholesterol biosynthesis. HMG Co-A reductase is an important enzyme in the process of converting HMG CoA to mevalonate. HMG CoA reductase is associated with lovastatin at higher concentrations, than HMG CoA, and as a result, it acts as a competitive inhibitor with the substrate and blocks the production of mevalonate and then inhibits the cholesterol biosynthesis (Tobert et al. 2003) . Hence, lovastatin is used as an effective drug for the treatment of hypercholesterolemia. Of many statin molecules, lovastatin and mevastatin are natural, while other statins like rosuvastatin, simvastatin, pravastatin, fluvastatin, atrovastin, cerivasatin, are produced semi-synthetically from lovastatin (Jonathan 2003) . Many of the 191 soil dwelling fungi such as Aspergillus, Gymnoascus, Hypomyces, Monascus, Paecilomyces, Penicillium, Phoma, Phythium, Pleurotus, Scopolariopsis, and Trichoderma are reported as lovastatin producers (Szakacs 1998 , Manzoni 1999 , Manzoni 2002 , Bizukojc & Stanislaw 2009 , Cabral et al. 2010 .
The main objective of the present study was to discover new producers of lovastatin in edible mushrooms by rapid screening of lovastatin by Candida albicans bioassay method, TLC and UV spectral analysis, which are simple and sensitive and can also be confirmed through HPLC.
Materials & Methods

Collection of mushrooms
Basidiocarps of wild mushrooms were collected from different regions of Bangalore, Karnataka and from Manipur during the monsoon season June-September (2014), Singer (1975) and Arora et al. (1986) classification was used to identify the mushrooms belonging to the subdivision Basidiomycotina. Seven mushrooms were collected and identified and three species belonged to the order Aphylloporales (Pleurotus ostreatus, Schizophyllum commune, Ganoderma applanatum), three species to the order Agaricales (Tricholoma giganteum, Calocybe indica, Agaricus campestris); and one species belonging to the order Tremellales -jelly fungi (Auricularia auricula) (Fig. 1) . Pure cultures of mushrooms were isolated as suggested by Pushpa et al. (2014) . The mushrooms were placed at 40-45 0 C in a hot air oven for the process of complete dehydration and preserved in an air tight container for further studies.
Extraction of lovastatin
The extraction of lovastatin was done as explained by Siamak et al. (2003) . The dried basidiocarps were made in to fine powder and homogenized with ethyl and acidified to pH 3 by using HCl. The extract was taken in the Eppendorf tube and kept in the rotary shaker at 260 rpm for 2 hours at 28°C. After that it was again centrifuged at 10000 rpm for 5 minutes the supernatant was collected and used for further studies.
Screening of lovastatin
Bioassay of HMG CoA reductase inhibitor using Candida albicans
The method for screening lovastatin producing isolates was adopted as suggested by Prabhakar et al. (2011) , briefly potato dextrose agar was prepared and poured into sterile Petri dish in aseptic conditions and the media was allowed to solidify. Using a cork borer, wells were aseptically made on the surface of the solidified media and 24 hours old broth culture of Candida albicans was swabbed on to the surface of the media. The extract of different isolates was loaded into the well, ethyl acetate was used as negative control and standard lovastatin was used as the positive control. All the inoculated plates in triplicates were incubated at 28−30 0 C for 24−48 hours and observed for the zone of inhibition.
Analysis of lovastatin using thin layer chromatography (TLC)
TLC was used to analyse the presence of lovastatin in the extracted samples as suggested by Samiee (2003) , Siamak (2003) and Atalla et al. (2008) . All extracts and the standard were spotted on the silica plate. The mobile phase was dichloromethane: ethyl acetate in the ratio of 70:30 v/v. All the plates were observed under UV radiation at 254 nm. For further convenience and analysis, the bands were stained with iodine vapor and Rf values was calculated and compared with that of standard lovastatin.
UV spectrometric analysis of lovastatin
The bands which show the Rf values similar to that of standard lovastatin were scrapped off and eluted with 1 ml of acetonitrile solvent and filtered. The λ max of the samples was determined at 238 nm using UV-Vis spectrophotometer. Further, the optical density of the sample was measured at 238 192 nm and the concentration of the lovastatin was calculated using the standard graph of lovastatin (Lingappa et al. 2004 ).
Confirmation of lovastatin using high performance liquid chromatography (HPLC)
The extracted lovastatin was dissolved in 1 ml of acetonitrile and 0.1 ml of 0.1% of phosphoric acid incubated for 30 minutes and centrifuged at 1500 rpm for 10 minutes. The supernatant was injected in the HPLC column C-18 (250 × 46 cm) was added with eluent acetonitrile and phosphate acid 60:40 (v/v), the eluent rate was 1.5 ml/minute, detector ultraviolet (UV) at 238 nm and the temperature of the column was 30 0 C (Samiee et al. 2003) .
Results & Discussion
Screening of lovastatin extracted from different fungal isolates
Bioassay of lovastatin by well method using Candida albicans The screening of potential lovastatin producing mushrooms was carried out by measuring the zone of inhibition around the well, where the extracted lovastatin sample was loaded. The diam. of zone of inhibition ranged from 2−2.8 cm (Table 1) and Fig 1. Tricholoma giganteum produced a maximum zone of inhibition. The difference in clear zones may be due to the variation of physiology and genetic characteristics of the specimens, ability of the lovastatin to diffuse in the agar, and incubation period (Vilches Ferrón et al. 2005) . The mechanism of sensitivity towards lovastatin is that lovastatin in ethyl acetate extract is in the form of β-hydroxy acid, which is an antifungal agent. The cell membrane of C. albicans contains a lipid bilayer. The composition of the cell wall comprises sterols, which is the target of antifungal activity, the enzyme that is involved in the cell wall synthesis. The mechanism of anti-yeast inhibition was mycosin contact directly with the sterol in the cell membrane, causing leaks in the membrane and the loss of the intracellular component, mycosin attaches to RNA and inhibits the protein synthesis, while mycosin inhibits ergosterol synthesis, causing the increase of membrane permeability and the damage of the membrane (Ganiswara et al. 1985) . 
Rapid confirmation of lovastatin by thin layer chromatography
To ensue whether the zone of inhibition exhibited by different isolates in bioassays were due to lovastatin activity, an ethyl acetate extract from different isolates were subjected to TLC for rapid confirmation (Fig. 2) . Six of the seven isolates produced an Rf similar as that of standard lovastatin. TLC confirmed that the inhibition of growth of C. albicans in the bioassay was due to the lovastatin. Our results concur with those of Lingappa (2004) , Prabhakar & Lingappa (2011) , Mangunwardoyo et al. (2012) , Chaynika (2014) and Dhar et al. (2015) . Determination of lovastatin by UV analysis Quantitative estimation of lovastatin was carried out for different isolates using a UV-Vis spectrophotometer. The spectral studies of standard lovastatin revealed a maximum absorption peak (λ max) at 238 nm. The results observed under these studies were in good agreement with the data published in Merck Index (Lingappa et al. 2004) . Therefore, 238 nm was considered as the constant for all the culture samples to measure the OD for lovastatin. The absorbance of the different concentration of standard lovastatin ranging from 10−100µg/ml was measured and a standard graph was prepared to obtain a linear curve. The OD of different mushroom lovastatin extract was plotted on the standard graph to obtain the concentration of the lovastatin produced in each of the sample. The concentration of lovastatin in mushrooms ranged from 17−38µg/ml respectively Schizophyllum commune and Pleurotus ostreatus produced the highest concentrations, viz 38 µg/ml and 30 µg/ml respectively. Agaricus campestris, Auricularia auricular, Calocybe indica, Ganoderma applanatum and Tricholoma giganteum also produced lovastatin. The presence of lovastatin in Pleurotus has been reported by Gunde et al. (1973) and Alarcón et al. (2003) . However the presence of lovastatin in Schizophyllum commune and Tricholoma giganteum is reported for the first time. 
HPLC analysis
The extracts of lovastain from different isolates were subjected to HPLC analysis to confirm the amount of lovastatin produced. Chromatogram analysis indicated the peak of lovastatin standard with the retention time of 12.45 minutes (Fig. 3) . The extracts of the fungal samples were eluted at a retention time of 12.770 minutes for Tricholoma giganteum and 12.450 mins for Schizophyllum commune (Fig. 4) , which were much similar to the retention time obtained from the standard. It was also confirmed form HPLC analysis that the concentration of lovastatin in Schizophyllum commune was 43.3 ppm, and Tricholoma giganteum 0.52 ppm. Hence, from this investigation it was concluded that rapid method of determination of lovastatin can also be employed to screen lovastatin producing fungal isolates. HPLC confirmed that the production of lovastatin in Schizophyllum commune an edible 194 wild mushroom which has the highest potential for the production of lovastatin, hence this mushroom could be cultivated and can be used as a food source and exploited commercially for the production of lovastatin. The presence of lovastatin in the mushroom Pleurotus ostreatus, P. saca and P. sapidus was confirmed by Cimerman (2006) and Radha & Lakshmanan (2013) . 
